Iceland· IS-EU/1/17/1182/001-004

Emtricitabine/Tenofovir disoproxil Krka d.d.

A tenofovir disoproxil and emtricitabine product containing emtricitabinum inn,tenofovir disoproxil succinate, registered in Iceland by Krka d.d. Novo mesto*. The same ATC class is registered in 13 of our 19 countries.

ATC J05AR03

Checked against Icelandic Medicines Agency (Iceland) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about emtricitabinum inn,tenofovir disoproxil succinateAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Tenofovir disoproxil and emtricitabine is registered in 13 of 19 countries.

Countries holding a registration under ATC J05AR03 (tenofovir disoproxil and emtricitabine), each read from that country’s own register.

This record: Iceland, from Icelandic Medicines Agency (Iceland)
8 of them publish a price we can compare per daily dose

Search tenofovir disoproxil and emtricitabine products by name

Tenofovir disoproxil and emtricitabine · ATC J05AR03

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Icelandic Medicines Agency (Iceland)

Active substance: Emtricitabinum INN,Tenofovir disoproxil succinate
Manufacturer: Krka d.d. Novo mesto*
Country: Iceland (IS)
ATC code: J05AR03
ATC class: Tenofovir disoproxil and emtricitabine
Reimbursed: Not published by this register
Source register: Icelandic Medicines Agency (Iceland)
Last checked: September 29, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

9 interactions on record for tenofovir disoproxil and emtricitabine.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check tenofovir disoproxil and emtricitabine against other medicines How interaction checks work

Tenofovir disoproxil and emtricitabine · interactions on record

9 records

9 more interactions with mechanism and management, from a commercially licensed source.

Mechanism and what to do, in the interaction check

Interaction register. Grades as the source publishes them.

Same medicine, other countries

Tenofovir disoproxil and emtricitabine in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tenofovir disoproxil and emtricitabine products

Authorised across Europe · EMA

The same active substance is authorised in 25 EEA countries. Names it is sold under:

Austria · Emtricitabin/Tenofovir Sandoz, Emtricitabin/Tenofovirdisoproxil Stada
Belgium · Emtricitabin/Tenofovir Disoproxil Ab
Cyprus · Exatron
Germany · Emtenovo, Emtricitabin Tenofovirdisoproxil Zentiva
Denmark · Emtricitabin/Tenofovirdisoproxil Tillomed, Emtricitabine/Tenofovir Disoproxil "sandoz"
Estonia · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Sandoz
Spain · Emtricitabina/Tenofovir Disoproxilo Aurovitas, Emtricitabina/Tenofovir Disoproxilo Glenmark
Finland · Emtricitabine / Tenofovir Disoproxil Stada, Emtricitabine/Tenofovir Disoproxil Accordpharma
France · Emtricitabine/ Tenofovir Disoproxil Sandoz, Emtricitabine/Tenofovir Disoproxil Accord
United Kingdom (Northern Ireland) · Emtricitabin/Tenofovirdisoproxil Amarox, Emtricitabine/ Tenofovir Disoproxil
Greece · Argiodin, Emtricitabin/Tenofovir Disoproxil Accord
Croatia · Emtricitabin/Tenofovirdizoproksil Pliva
Hungary · Dunotrisin, Emtricitabine/Tenofovir Disoproxil Accordpharma
Ireland · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Clonmel
Italy · Emtricitabina E Tenofovir Disoproxil Aequilibrium Pharma, Emtricitabina E Tenofovir Disoproxil Aurobindo
Liechtenstein · Emtricitabine/Tenofovir Disoproxil Mylan, Emtricitabine/Tenofovir Disoproxil Zentiva
Lithuania · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Sandoz
Latvia · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Teva
Netherlands · Emtricitabine Tenofovir Disoproxyl Fumarate Aurobindo, Emtricitabine/Tenofovir Disoproxil Accordpharma
Norway · Emtricitabin/Tenofovirdisoproxil Tillomed, Emtricitabine/ Tenofovir Disoproxil Cipla
Poland · Emtricitabine + Tenofovir Disoproxil Aurovitas, Emtricitabine + Tenofovir Disoproxil Tillomed
Portugal · Emtricitabina + Tenofovir Accord, Emtricitabina + Tenofovir Disoproxil
Romania · Emtricitabină/Tenofovir Disoproxil Stada, Emtricitabină/Tenofovir Disoproxil Teva
Sweden · Emtricitabine/Tenofovir Disoproxil Accordpharma, Emtricitabine/Tenofovir Disoproxil Glenmark
Slovenia · Emtricitabin/Dizoproksiltenofovirat Teva

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Icelandic Medicines Agency (Iceland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d2ac82f0-5589-4ff0-889a-5f3102ca1d8f
GET /v1/drugs/d2ac82f0-5589-4ff0-889a-5f3102ca1d8f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmuhúðuð tafla",
  "source": "lyfjastofnun",
  "atc_raw": "J05AR03",
  "marketed": false,
  "strength": "200 mg/245 mg",
  "ma_number": "EU/1/17/1182/001-004",
  "substance": "Emtricitabinum INN,Tenofovir disoproxil succinate",
  "other_info": "Ávísun lyfsins er bundin við sérfræðinga í smitsjúkdómum.\r\nMarkaðssetning á Íslandi er háð því að Lyfjastofnun hafi staðfest að sérstök skilyrði er varða öryggi og verkun við notkun lyfsins séu uppfyllt.",
  "legal_status": "(R Z) Sérfræðingsmerkt (og lyfseðilsskylt)",
  "ma_issued_serial": "42853"
}

API reference MCP server Plans

See everything about tenofovir disoproxil and emtricitabine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console